Correlation Between Cyteir Therapeutics and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Cyteir Therapeutics and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and Lixte Biotechnology.
Diversification Opportunities for Cyteir Therapeutics and Lixte Biotechnology
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cyteir and Lixte is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Cyteir Therapeutics and Lixte Biotechnology
If you would invest 160.00 in Lixte Biotechnology Holdings on August 26, 2024 and sell it today you would earn a total of 3.00 from holding Lixte Biotechnology Holdings or generate 1.88% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 4.55% |
Values | Daily Returns |
Cyteir Therapeutics vs. Lixte Biotechnology Holdings
Performance |
Timeline |
Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lixte Biotechnology |
Cyteir Therapeutics and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cyteir Therapeutics and Lixte Biotechnology
The main advantage of trading using opposite Cyteir Therapeutics and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Neurobo Pharmaceuticals | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |